Amphetamine use and Sexual Practices - Anette Skårner, Bengt Svensson, 2013
AIM – This article examines how men and women who have left problematic drug use describe their own previous use of amphetamine in the context of sexual activit...
A new cloud-based platform utilizes wearable sensors to enable a patient to do physical therapy at home while a physical therapist remotely monitors their progress.
Researchers at Case Western Reserve University have combined a muscle from a sea slug’s mouth as well as bundles of its neurons and nerves with flexible 3D printed components to build biohybrid rob...
Francis Bitonti, Studio Bitonti, talks about the ways advanced design software has enabled generative design to flourish in the field of bioengineering in recent years. This algorithm-based method ...
Researchers at the Southwest Research Institute now are tackling the challenge of 3D-printing nonbiological parts that mimic the actual physical properties of human tissue.
Doctors target cancer cells with new ultrasound technique
Using ultrasound, researchers at University California, San Diego, are working on a way to remotely control engineered T cells once they have been injected into patients for more targeted treatment.
Georgia Tech Engineers created an organization to develop standards and production processes designed to mass produce life-saving cell-based therapeutics at affordable prices. Via AABME
Engineers use Microsoft HoloLens to design better products
More bioengineers are taking a serious look at how virtual and augmented reality tools, like Microsoft's HoloLens can expand their design capabilities.
Join Marc Horner, Ph.D., Technical Lead, Healthcare at ANSYS, Inc. as he explains the concept of the digital twin and computational modeling as a critical element of modern healthcare in a free webina
Artios Pharma develops drug program for nuclease inhibitors
A new nuclease inhibitor drug program could lead to the commercialization of novel DNA Damage Response treatments for female breast, ovarian, and other types of cancers.
Scientists successfully used CRISPR-Cas9 to repair a disease-causing genetic flaw in viable human embryos and prevent the mutation from being to future generations. What's next? Via AABME.org
Cellular Biomedicine Group GE Healthcare to scale therapies
Cellular Biomedicine Group, a clinical-stage biopharmaceutical company, recently partnered with GE Healthcare to produce therapies at scale for clinical trials. Via AABME
Medical device makers wonder how much to trust modeling
Medical device makers lag other industries in their use of computer models. One of the big issues is how much can researchers, regulators, and engineers trust their models and simulation?